Alignment Healthcare annual stock-based compensation
2019
2020
2021
2022
2023
2024
2025
Alignment Healthcare Stock-Based Compensation Growth & History (ALHC)
Alignment Healthcare's stock-based compensation was $62.1M for fiscal 2025.
View full Alignment Healthcare company overviewAlignment Healthcare annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $62.1M | −$9.1M | −12.72% |
| 2024 | 2024-12-31 | $71.1M | $4.3M | +6.43% |
| 2023 | 2023-12-31 | $66.8M | $66.8M | — |
| 2022 | 2022-12-31 | $0 | −$621,000 | — |
| 2021 | 2021-12-31 | $621,000 | $175,000 | +39.24% |
| 2020 | 2020-12-31 | $446,000 | $446,000 | — |
| 2019 | 2019-12-31 | $0 | — | — |
Alignment Healthcare quarterly stock-based compensation
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $18.2M | $2.6M | +16.85% |
| Q1 2026 | 2026-03-31 | $14.0M | −$3.2M | −18.43% |
| Q4 2025 | 2025-12-31 | $13.1M | −$3.1M | −19.22% |
| Q3 2025 | 2025-09-30 | $16.2M | −$1.0M | −5.97% |
| Q2 2025 | 2025-06-30 | $15.6M | −$1.2M | −7.33% |
| Q1 2025 | 2025-03-31 | $17.2M | −$3.7M | −17.58% |
| Q4 2024 | 2024-12-31 | $16.2M | $584,000 | +3.73% |
| Q3 2024 | 2024-09-30 | $17.3M | $3.7M | +27.19% |
| Q2 2024 | 2024-06-30 | $16.8M | $1.1M | +7.34% |
| Q1 2024 | 2024-03-31 | $20.9M | −$1.1M | −5.11% |
| Q4 2023 | 2023-12-31 | $15.7M | — | — |
| Q3 2023 | 2023-09-30 | $13.6M | −$5.1M | −27.39% |
| Q2 2023 | 2023-06-30 | $15.6M | $3.5M | +29.23% |
| Q1 2023 | 2023-03-31 | $22.0M | −$6.1M | −21.64% |
| Q3 2022 | 2022-09-30 | $18.7M | −$11.8M | −38.75% |
| Q2 2022 | 2022-06-30 | $12.1M | −$18.8M | −60.83% |
| Q1 2022 | 2022-03-31 | $28.0M | −$3.7M | −11.77% |
| Q3 2021 | 2021-09-30 | $30.5M | $30.2M | +9936.51% |
| Q2 2021 | 2021-06-30 | $30.9M | $30.5M | +8724.86% |
| Q1 2021 | 2021-03-31 | $31.8M | $31.5M | +9650.61% |
| Q3 2020 | 2020-09-30 | $304,000 | — | — |
| Q2 2020 | 2020-06-30 | $350,000 | — | — |
| Q1 2020 | 2020-03-31 | $326,000 | — | — |
Alignment Healthcare stock-based compensation trends
Over the last five fiscal years, Alignment Healthcare's stock-based compensation increased from $446,000 to $62.1M, a change of $61.6M. The latest reported quarter, Q2 2026, shows $18.2M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alignment Healthcare source filings ↗